PReP could end mother to child HIV transmission

The HIV transmission rate from mother to child is incredibly low under the control of proper anti-retroviral treatments, one in particular – PReP. Currently, PReP is only available in a trial situation and can cost upwards of $800 for a months dosage. The chance of passing on the HIV virus is a big concern to any sero-discordant couple, so this new medication could mean wonders for families around Australia.

Producers:

• Jake Morcom

Speakers:

• Dr Jennifer Power - Research Fellow from La Trobe University and Coordinator of HIV Futures Study